Global Genomics Market
Sizing, Segmentation, & Growth Forecast (2025-2030)
Last updated: August 2026
Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.
Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).
1. Summary
The Global Genomics Market was valued at $44.2 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 16.2% CAGR, to an estimated market size of $93.7 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.
2. Market Definition
The global genomics market comprises the development and application of technologies, instruments, consumables, and services used to analyze the structure, function, evolution, and mapping of genomes. The scope includes Next-Generation Sequencing (NGS), polymerase chain reaction (PCR), microarrays, and bioinformatics tools applied across clinical diagnostics, drug discovery, precision medicine, and agricultural biotechnology, while excluding general laboratory equipment not specific to genetic analysis.
3. Trends & Demand Drivers
Several key trends are expected to significantly impact the Genomics Market in the period 2025-30:
- The integration of Artificial Intelligence (AI) and machine learning is revolutionizing the interpretation of vast genomic datasets and variant identification.
- Rapidly declining costs of Next-Generation Sequencing (NGS) are enabling the transition toward the sub-$200 human genome, increasing clinical accessibility.
- A significant shift from reactive healthcare to precision medicine is driving the adoption of companion diagnostics and tailored therapeutic regimens.
- Large-scale government-led initiatives, such as the 'All of Us' program and UK Biobank, are creating massive population-level genomic repositories.
- The emergence of multi-omics approaches is combining genomics with transcriptomics and proteomics to provide a holistic view of biological systems.
- Advancements in gene editing technologies like CRISPR-Cas9 are accelerating the development of novel gene therapies and functional genomics research.
- Increasing clinical adoption of liquid biopsy and non-invasive prenatal testing (NIPT) is expanding the market for early disease detection.
4. Market Breakdown
The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:
Geographies
- North America
- Europe
- Asia-Pacific
- Rest of World
Segments
- Consumables
- Instruments and Systems
- Services and Software